Nothing Special   »   [go: up one dir, main page]

Barrows et al., 2018 - Google Patents

Biochemistry and molecular biology of flaviviruses

Barrows et al., 2018

View HTML
Document ID
2061587168918740624
Author
Barrows N
Campos R
Liao K
Prasanth K
Soto-Acosta R
Yeh S
Schott-Lerner G
Pompon J
Sessions O
Bradrick S
Garcia-Blanco M
Publication year
Publication venue
Chemical reviews

External Links

Snippet

Flaviviruses, such as dengue, Japanese encephalitis, tick-borne encephalitis, West Nile, yellow fever, and Zika viruses, are critically important human pathogens that sicken a staggeringly high number of humans every year. Most of these pathogens are transmitted by …
Continue reading at www.ncbi.nlm.nih.gov (HTML) (other versions)

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA Viruses positive-sense
    • C12N2770/00011—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA Viruses positive-sense ssRNA Viruses positive-sense
    • C12N2770/24011—Flaviviridae
    • C12N2770/24111—Flavivirus, e.g. yellow fever virus, dengue, JEV
    • C12N2770/24122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof

Similar Documents

Publication Publication Date Title
Barrows et al. Biochemistry and molecular biology of flaviviruses
Murugesan et al. Dengue virus
Khan et al. Dengue overview: An updated systemic review
Hobson-Peters et al. A recombinant platform for flavivirus vaccines and diagnostics using chimeras of a new insect-specific virus
Laureti et al. Flavivirus receptors: diversity, identity, and cell entry
Gardner et al. Yellow fever: a reemerging threat
Lee et al. Probing molecular insights into Zika virus–host interactions
Singh et al. Zika virus–emergence, evolution, pathology, diagnosis, and control: current global scenario and future perspectives–a comprehensive review
Rodriguez-Roche et al. Understanding the dengue viruses and progress towards their control
Kim et al. A single N-linked glycosylation site in the Japanese encephalitis virus prM protein is critical for cell type-specific prM protein biogenesis, virus particle release, and pathogenicity in mice
Carro et al. Beyond the surface: Endocytosis of mosquito-borne flaviviruses
Trus et al. CpG-recoding in Zika virus genome causes host-age-dependent attenuation of infection with protection against lethal heterologous challenge in mice
Olagnier et al. Dengue virus immunopathogenesis: lessons applicable to the emergence of Zika virus
Kleinert et al. Yellow fever: Integrating current knowledge with technological innovations to identify strategies for controlling a re-emerging virus
Beasley Recent advances in the molecular biology of West Nile virus
Rajah et al. Zika virus: emergence, phylogenetics, challenges, and opportunities
Li et al. Methylene blue is a potent and broad-spectrum inhibitor against Zika virus in vitro and in vivo
Kudchodkar et al. Rapid response to an emerging infectious disease–lessons learned from development of a synthetic DNA vaccine targeting Zika virus
Estévez-Herrera et al. Zika virus pathogenesis: a battle for immune evasion
Klitting et al. What does the future hold for yellow fever virus?(II)
Pauli et al. West nile virus
Choy et al. A non-structural 1 protein G53D substitution attenuates a clinically tested live dengue vaccine
Chesnut et al. In vitro and in silico models to study mosquito-borne flavivirus neuropathogenesis, prevention, and treatment
Valiakos et al. West Nile virus: Basic principles, replication mechanism, immune response and important genetic determinants of virulence
Terasaki et al. A single-cycle replicable Rift Valley fever phlebovirus vaccine carrying a mutated NSs confers full protection from lethal challenge in mice